The Cure(ious)TM
Munjal Shah, Co-Founder and CEO of Hippocratic AI, was recently featured in “The Cure(ious)” series by the New York Stock Exchange (NYSE). This series invites
A generative artificial intelligence startup focused on building foundation models for health care and using it to improve patient outcomes, lower health care costs, and address the growing shortage of health care workers worldwide.
Founded by generative AI researchers, hospital administrators, physicians, and Medicare experts, Hippocratic AI has developed a safety-focused large language model to provide nondiagnostic health care services. Its large language model outperformed Open AI’s GPT-4 on 105 of 114 health care exams and certifications. Hippocratic AI has received a total of $120M in funding and is backed by leading investors, including General Catalyst, Andreessen Horowitz, Premji Invest, and SV Angel.
Munjal Shah, Co-Founder and CEO of Hippocratic AI, was recently featured in “The Cure(ious)” series by the New York Stock Exchange (NYSE). This series invites
I was recently a guest speaker at CES, where we delved into a range of compelling topics. The discussion highlighted the critical role of empathy
Hippocratic AI is deepening its leadership bench with seven executive hires following its $141 million Series B funding round, reinforcing its commitment to scaling safety-focused
Hippocratic AI is scaling up its leadership team with several high-profile executive hires, each tasked with expanding the company’s reach across new market sectors and
Hippocratic AI is entering a new phase of growth, marked by the addition of seasoned leaders who bring deep expertise across healthcare sectors and global